Literature DB >> 7745702

Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants.

T R Reddy1, G Kraus, O Yamada, D J Looney, M Suhasini, F Wong-Staal.   

Abstract

Virion infectivity factor (vif), a gene found in all lentiviruses, plays an essential role in virus replication in certain target cells. We examined the replication competence of the human immunodeficiency virus type 2 (HIV-2) vif mutant in different T-cell lines and primary cells in comparison with that of the HIV-1 vif mutant. Both mutant viruses were unable to replicate in peripheral blood-derived mononuclear cells but replicated with wild-type efficiency in certain T-cell lines, such as SupT1 and MOLT-4/8. These results confirm the importance of vif in the infection of relevant target cells and imply that some cellular factor(s) could compensate for vif function. However, HIV-1 and HIV-2 vif mutant viruses also show differential replications in other cell lines, suggesting either different threshold requirements for the same cellular factor(s) or the involvement of different factors to compensate for vif-1 and vif-2 functions. By cross complementation experiments, we showed that vif-1 and vif-2 have similar functions. Our studies further indicate the existence of two kinds of nonpermissive cells: H9 is unable to complement HIV-1 delta vif but is susceptible to a one-round infection with HIV-1 delta vif produced from permissive cells. In contrast, U937 is nonpermissive for HIV-2 delta vif produced from permissive cells but, once infected, is able to complement the delta vif function. In both types of nonpermissive cells, a step prior to proviral DNA synthesis is affected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745702      PMCID: PMC189069          DOI: 10.1128/JVI.69.6.3549-3553.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

Review 2.  The biochemistry of AIDS.

Authors:  Y N Vaishnav; F Wong-Staal
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

3.  Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera.

Authors:  U Wieland; J E Kühn; C Jassoy; H Rübsamen-Waigmann; V Wolber; R W Braun
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

4.  Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus.

Authors:  K J Garvey; M S Oberste; J E Elser; M J Braun; M A Gonda
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

5.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.

Authors:  D Trono
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  Inhibition of growth of HIV by human natural interferon in vitro.

Authors:  O Yamada; N Hattori; T Kurimura; M Kita; T Kishida
Journal:  AIDS Res Hum Retroviruses       Date:  1988-08       Impact factor: 2.205

7.  The sor gene of HIV-1 is required for efficient virus transmission in vitro.

Authors:  A G Fisher; B Ensoli; L Ivanoff; M Chamberlain; S Petteway; L Ratner; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

8.  Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products.

Authors:  E D Garrett; L S Tiley; B R Cullen
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein.

Authors:  B Guy; M Geist; K Dott; D Spehner; M P Kieny; J P Lecocq
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

View more
  16 in total

1.  Functional analysis of vif genes derived from various primate immunodeficiency viruses.

Authors:  Y Yamamoto; Y Saito; S Iida; J Asano; S Sone; A Adachi
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

2.  Feline immunodeficiency virus Vif localizes to the nucleus.

Authors:  U Chatterji; C K Grant; J H Elder
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission.

Authors:  J H Simon; D L Miller; R A Fouchier; M A Soares; K W Peden; M H Malim
Journal:  EMBO J       Date:  1998-08-10       Impact factor: 11.598

4.  Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

Authors:  M A Khan; C Aberham; S Kao; H Akari; R Gorelick; S Bour; K Strebel
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.

Authors:  M K Karczewski; K Strebel
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Identification of a functionally important amino acid residue near to the amino-terminus of the human immunodeficiency virus type 1 Vif protein.

Authors:  M Boyce; P Willingmann; M McCrae
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

7.  Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.

Authors:  H Zhang; R J Pomerantz; G Dornadula; Y Sun
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.

Authors:  Sandra Kao; Mohammad A Khan; Eri Miyagi; Ron Plishka; Alicia Buckler-White; Klaus Strebel
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.

Authors:  Navid Madani; Robert Millette; Emily J Platt; Mariana Marin; Susan L Kozak; Donald B Bloch; David Kabat
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Identification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene.

Authors:  T R Reddy; G Kraus; M Suhasini; M C Leavitt; F Wong-Staal
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.